Device Hydratome Rx 44_endo

Hydratome Rx 44

Payments companies reported to CMS as associated with Hydratome Rx 44. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,478associated payments (2023-2025)
47clinicians with associated payments
1company reporting

By year

2023 $1,130
2024 $161
2025 $186

Payments reported as associated with Hydratome Rx 44, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $839
Internal Medicine $172
Nurse Anesthetist, Certified Registered $118
Acute Care (Clinical Nurse Specialist) $75.79
Adult Health (Nurse Practitioner) $68.35
Surgery $49.85

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hydratome Rx 44

These are the largest totals companies reported as associated with Hydratome Rx 44. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Uzma Siddiqui Chicago, IL Gastroenterology (Internal Medicine) $112.29
Sami Elamin Boston, MA Internal Medicine $108.31
Iman Boston Boston, MA Gastroenterology (Internal Medicine) $108.31
Tyler Berzin Boston, MA Gastroenterology (Internal Medicine) $108.30
Vicki Oliver Oklahoma City, OK Acute Care (Clinical Nurse Specialist) $75.79
Brock Amos Longview, WA Nurse Anesthetist, Certified Registered $49.85
Peter Francisco Cooperstown, NY Gastroenterology (Internal Medicine) $49.85
Elena Cahoone Cooperstown, NY Adult Health (Nurse Practitioner) $49.85
Pascale Raymond Cooperstown, NY Internal Medicine $49.85
Carmine Catalano Cooperstown, NY Gastroenterology (Internal Medicine) $49.85

Prescribed Hydratome Rx 44?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.